Daniel J. Lippis - 12 Feb 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
12 Feb 2026
Net transactions value
-$34,597
Form type
4
Filing time
17 Feb 2026, 17:16:02 UTC
Previous filing
09 Jan 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lippis Daniel J. CVP, TAVR ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 17 Feb 2026 0002004380

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Award $0 +12,820 +58% $0.000000 34,822 12 Feb 2026 Direct F1
transaction EW Common Stock Tax liability $19,574 -258 -0.74% $75.87 34,564 16 Feb 2026 Direct
transaction EW Common Stock Tax liability $15,022 -198 -0.57% $75.87 34,366 17 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.